Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.50
Bid: 53.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.887%)
Open: 53.50
High: 53.50
Low: 53.50
Prev. Close: 53.50
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Harwood Capital LLP

10 Feb 2020 14:00

RNS Number : 5210C
Harwood Capital LLP
10 February 2020
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Harwood Capital LLP on behalf of funds and private clients managed and/or advised by Harwood Capital LLP.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

North Atlantic Smaller Companies Investment Trust Plc ("NASCIT") for which Harwood Capital LLP acts as investment adviser.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Frenkel Topping Group Plc ("Frenkel Topping")

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

7 February 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 0.5p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

-

-

-

-

(2) Cash-settled derivatives:

 

-

-

-

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

-

-

-

-

 

TOTAL:

-

-

-

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Harwood Capital LLP acts as investment adviser to NASCIT, a UK investment trust listed on the Main Market of the London Stock Exchange.

 

Christopher Mills is a director and the majority shareholder, alongside his sons, of Harwood Capital Management Limited, which is a designated corporate member and the controller of Harwood Capital LLP. Mr Mills, as Chief Executive of NASCIT, has control of investment decisions in relation to NASCIT's investment portfolio subject to oversight by the board of NASCIT.

 

NASCIT is interested in 15,100,000 ordinary shares of 0.5p each in Frenkel Topping, representing approximately 19.99% of the total voting rights.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

10 February 2020

Contact name:

James Agnew

Telephone number:

020 7640 3200

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEEURVORRAUUAAR
Date   Source Headline
14th May 20147:00 amRNSAGM Statement
24th Mar 20147:00 amRNSPreliminary Results
24th Feb 201412:16 pmRNSAppointment of Non-Executive Director
20th Feb 20147:00 amRNSNotice of Preliminary Results
20th Jan 20143:33 pmRNSTrading Statement
9th Jan 201412:49 pmRNSNew Director Incentive Scheme
6th Dec 20139:58 amRNSHolding(s) in Company
12th Nov 20133:59 pmRNSHolding(s) in Company
11th Nov 201311:31 amRNSDirector/PDMR Shareholding
26th Sep 20138:51 amRNSHolding(s) in Company
25th Sep 201312:13 pmRNSHolding(s) in Company
6th Sep 20139:26 amRNSHolding(s) in Company
5th Sep 20132:34 pmRNSDirector/PDMR Shareholding
14th Aug 20133:17 pmRNSDirector/PDMR Shareholding - Replacement
14th Aug 20139:44 amRNSDirector/PDMR Shareholding and Group EBT Purchase
6th Aug 20132:28 pmRNSExercise of options
15th Jul 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSNotice of Interim Results
29th May 201310:42 amRNSResult of AGM
29th May 20139:16 amRNSDirector/PDMR Shareholding
29th May 20137:00 amRNSAGM Statement
21st May 20134:10 pmRNSHolding(s) in Company
17th May 20137:00 amRNSHolding(s) in Company
15th May 20133:56 pmRNSDirector/PDMR Shareholding
9th Apr 20137:00 amRNSPreliminary Results
3rd Apr 20132:57 pmRNSHolding(s) in Company
28th Feb 20137:00 amRNSTotal Voting Rights
12th Feb 20137:00 amRNSAcquisitions of Minority Interests in Subsidiaries
1st Feb 20134:49 pmRNSHolding(s) in Company
1st Feb 20131:54 pmRNSHolding(s) in Company
28th Jan 20137:00 amRNSNotice of Results
16th Jan 20137:00 amRNSTrading Update
30th Nov 20121:26 pmRNSHolding(s) in Company
23rd Oct 201211:23 amRNSDirector's Dealing and Group EBT Share Purchase
4th Oct 20127:00 amRNSFrenkel Topping implements new integrated platform
28th Sep 20127:00 amRNSTotal Voting Rights
10th Sep 201212:53 pmRNSDirector/PDMR Shareholding
29th Aug 201212:00 pmRNSExercise of Options
16th Jul 20127:00 amRNSInterim Results
2nd Jul 20122:07 pmRNSNotice of Interim Results
14th Jun 20126:25 pmRNSDirector/PDMR Shareholding
17th May 201211:55 amRNSResult of AGM
17th May 20127:00 amRNSAGM Statement
4th Apr 20121:42 pmRNSHolding(s) in Company
22nd Mar 20124:52 pmRNSHolding(s) in Company
20th Mar 201210:57 amRNSCalendar for 2011 Final Dividend
20th Mar 20127:00 amRNSFinal Results
22nd Feb 20124:44 pmRNSTrading Statement
12th Jan 20127:00 amRNSTrading Statement
30th Nov 20114:12 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.